Opportunity

Federal Register #DEA-1733

DEA Solicitation for Importer Registration of Controlled Substances (USP and Veterans Pharmaceuticals)

Buyer

Drug Enforcement Administration

Posted

June 30, 2026

Respond By

July 30, 2026

Identifier

DEA-1733

NAICS

424210

This opportunity concerns the registration of importers for controlled substances by the Drug Enforcement Administration (DEA) under the Department of Justice. - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - OEMs/Vendors: - United States Pharmacopeial Convention - Veterans Pharmaceuticals, Inc. - Products/Controlled Substances Requested: - United States Pharmacopeial Convention: - Marihuana Extract (drug code 7350), Schedule I - Marihuana (drug code 7360), Schedule I - Both for use as analytical reference standards for analytical testing of raw materials - Veterans Pharmaceuticals, Inc.: - Lysergic acid diethylamide (7315), Schedule I - Marihuana Extract (7350), Schedule I - Marihuana (7360), Schedule I - Tetrahydrocannabinols (7370), Schedule I - Mescaline (7381), Schedule I - 3,4-Methylenedioxyamphetamine (7400), Schedule I - 5-Methoxy-N, N-dimethyltryptamine (7431), Schedule I - Dimethyltryptamine (7435), Schedule I - Psilocybin (7437), Schedule I - Psilocyn (7438), Schedule I - Methamphetamine (1105), Schedule II - Intended for research and clinical trials - Unique/Notable Requirements: - Importation is strictly for research, clinical trials, or as analytical reference standards - No importation of finished dosage forms for commercial sale is permitted - DEA is soliciting public comments, objections, or requests for a hearing regarding these applications

Description

United States Pharmacopeial Convention has applied to be registered as an importer of basic classes of controlled substances, specifically Marihuana Extract and Marihuana. The company plans to import these substances for distribution as analytical reference standards to its customers for analytical testing of raw materials. No other activities for these drug codes are authorized for this registration. Comments or objections can be submitted electronically or in writing on or before July 30, 2026, and interested parties may request a hearing by the same date.

View original listing